Parmax Pharma Increases Authorized Share Capital to ₹10 Cr

Parmax Pharma Ltd has amended its Memorandum of Association (MOA) and adopted new Articles of Association (AOA) following approval at an Extraordinary General Meeting (EGM). The key amendment involves an increase in the company's authorized share capital from ₹6 Crores to ₹10 Crores, comprising 1 Crore equity shares of ₹10 each. The new Articles of Association have been adopted to align with the Companies Act, 2013, replacing the older ones based on the Companies Act, 1956. The amended MOA and AOA are available on the company's website.